Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
02/2006
02/09/2006WO2006014405A2 Sulfonamide-based compounds as protein tyrosine kinase inhibitors
02/09/2006WO2006014135A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
02/09/2006WO2006014134A1 Novel piperidine derivative for the treatment of depression
02/09/2006WO2006014024A1 Therapeutic agent for psychoneurotic disease
02/09/2006WO2006014012A2 Aromatic compounds
02/09/2006WO2003090691A3 Method and compositions for identifying anti-hiv therapeutic compounds
02/09/2006US20060030714 Reacting a 2,5-dihalopyridine with an alkyllithium and a enolizable aldehyde or ketone to form a 2-(optionally disubstituted hydroxymethyl)-5-halopyridine while quenching with a proton donor
02/09/2006US20060030713 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
02/09/2006US20060030712 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof
02/09/2006US20060030618 Vanilloid receptor ligands and their use in treatments
02/09/2006US20060030603 Novel aryl urea analogs and use thereof as antibacterial agents
02/09/2006US20060030601 Novel aminopyridine derivatives as mGluR5 antagonists
02/09/2006US20060030599 Sulphonamide derivatives
02/09/2006US20060030568 Crystal modificaion of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use
02/09/2006US20060030557 Substituted pyridines having antiangiogenic activity
02/09/2006US20060030553 Cell adhesion inhibitors
02/09/2006CA2576109A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
02/09/2006CA2576073A1 Novel piperidine derivative for the treatment of depression
02/09/2006CA2575894A1 Dual nk1/nk3 antagonists against schizophrenia
02/09/2006CA2574956A1 Heterocyclic acetophenone potentiators of metabotropic glutamate receptors
02/09/2006CA2573223A1 Aromatic compound
02/08/2006EP1623977A1 Intermediate compound which is used for the preparation of pioglitazone
02/08/2006EP1623973A1 Platinum complex
02/08/2006EP1622898A1 Processes for making thiazolidinedione derivatives and compounds thereof
02/08/2006EP1622891A1 Stable ammonium salts of alpha-liponic acid, the production there of and the use of the same
02/08/2006EP1622869A1 Glyoxalase inhibitors
02/08/2006EP1622867A1 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists
02/08/2006EP1622865A2 Novel bioisosteres of actinonin
02/08/2006EP1404696B1 Activators for oligonucleotide synthesis
02/08/2006EP1318978B1 N-acylsulfonamide apoptosis promoters
02/08/2006EP1187815B1 4-phenyl-pyrimidine derivatives
02/08/2006EP1183243B1 Short-acting benzodiazepines
02/08/2006EP1144348B1 Lta 4 hydrolase inhibitors
02/08/2006EP1131292B1 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides
02/08/2006CN1732175A Method for producing pyridoxine or an acid addition salt thereof
02/08/2006CN1732166A Novel herbicides
02/08/2006CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives
02/08/2006CN1732156A Biphenyl derivatives and their use as fungicides
02/08/2006CN1732154A Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
02/08/2006CN1732152A Phenethanolamine derivative for the treatment of respiratory diseases
02/08/2006CN1732146A Cycloalkyl inhibitors of potassium channel function
02/08/2006CN1732145A Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
02/08/2006CN1732002A Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
02/08/2006CN1730481A 5-aza-indole preparation method
02/08/2006CN1240683C Method for preparing 2-aminopyridine and alkyl derivative
02/08/2006CN1240682C Novel bactericide of 4-[3-(pyridine-4-yl)-3-substituted phenyl acryloyl] morpholine
02/08/2006CN1240677C Monofluoroalkyl derivatives
02/07/2006US6995269 Guanidinobenzamides
02/07/2006US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders
02/07/2006US6995178 Insecticidal anthranilamides
02/07/2006US6995172 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
02/07/2006US6995162 Substituted alkylamine derivatives and methods of use
02/07/2006US6995151 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
02/07/2006US6995110 Complex catalyst, process for producing the complex catalyst, and process for producing alcohol derivative with the complex catalyst
02/07/2006US6994283 Method for pulverizing to fine powder
02/07/2006CA2273479C 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
02/02/2006WO2006012320A1 Process for the preparation of 4-trifluoromethyl-2(1h)-pyridinone
02/02/2006WO2006012227A2 Amido compounds and their use as pharmaceuticals
02/02/2006WO2006011669A1 Novel cinnamic acid related compounds
02/02/2006WO2006011469A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
02/02/2006WO2006011050A2 Pyridine derivatives
02/02/2006WO2006011035A1 Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them
02/02/2006WO2006010775A1 Tyrosine derivatives as ppar-gamma-modulators
02/02/2006WO2006010637A2 Pyridinylamines
02/02/2006WO2006010546A2 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors
02/02/2006WO2005118541A3 Heterocyclic compounds and their use as aldosterone synthase inhibitors
02/02/2006WO2005113511A9 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
02/02/2006WO2005103032A3 Novel alkyne compounds having an mch-antagonistic effect, and medicaments containing said compounds
02/02/2006WO2005103002A3 Novel alkyne compounds with an mch-antagonistic action and medicaments comprising said compounds
02/02/2006WO2005084368A3 Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues
02/02/2006US20060025596 Method for deuteration or tritiation of heterocyclic ring
02/02/2006US20060025594 Small molecule entry inhibitors
02/02/2006US20060025474 Bisphenyl compounds useful as vitamin D3 receptor agonists
02/02/2006US20060025456 Serotonin reuptake inhibitors; dimethyl-(2-pyridin-3-yl-cyclohex-1-enylmethyl)-amine and the corresponding dihydrochloride; analgesics, anxiety disorders; side effects reduction
02/02/2006US20060025455 New 5-aryl pyridines as 11-beta inhibitors for the treatment of diabetes
02/02/2006US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
02/02/2006US20060025415 Compositions useful as inhibitors of voltage-gated sodium channels
02/02/2006US20060025404 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
02/02/2006US20060025396 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
02/02/2006DE102004033525A1 Verbessertes Verfahren zur Herstellung kernfluorierter Aromaten Improved process for preparing aromatic kernfluorierter
02/02/2006DE102004033021A1 Liquid pressure transmitting medium, useful in hydraulic component or machines, comprises ionic liquid as pressure transmitting medium
02/02/2006CA2575283A1 Method for the preparation of crystal forms of torsemide in a pure state
02/02/2006CA2574021A1 Tyrosine derivatives as ppar-gamma-modulators
02/02/2006CA2573777A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
02/02/2006CA2573409A1 Preparation of novel substituted haloarene compounds
02/02/2006CA2570903A1 N-hydroxyamide derivatives and use thereof
02/02/2006CA2570694A1 Amido compounds and their use as pharmaceuticals
02/01/2006EP1621195A2 The use of pyridinic NK-1 receptor antagonists for the treatment of brain, spinal or nerve injury
02/01/2006EP1620445A2 Method and compositions for identifying anti-hiv therapeutic compounds
02/01/2006EP1620404A1 Novel process for the preparation of 2-aminomethylpyridine derivatives
02/01/2006EP1620397A1 Hydroxamic acids useful in the treatment of hyper-proliferative disorders
02/01/2006EP1620102A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
02/01/2006EP1620086A1 Compounds that modulate ppar activity and methods of preparation
02/01/2006EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
02/01/2006EP1453808B1 Pyridine-3-sulfonyl compounds as pesticidal agents
02/01/2006EP1444205B1 Method for producing 2-halogen-pyridine-carboxylic acid amides
02/01/2006EP0970057B1 Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof
02/01/2006EP0859613B1 Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system
02/01/2006CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
02/01/2006CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha